Osteoarthritis (OA) is one of the most disabling degenerative diseases affecting the elderly \[[@B1]\]. While the reported prevalence of knee OA is approximately 3% among individuals between the ages of 45 to 54 years, this number rises to 27% for those between 63 and 69 years, and increases once again to 44% for persons above the age of 80 years \[[@B2]\]. The critical challenge is to develop physical activity **(PA)** programs that will encourage individuals with OA to not only to initiate, but also to maintain improvements in exercise behaviour over a long-term period. This study implemented relatively low-cost community-based walking programs at existing walking clubs.

The second part of this manuscript examines the effect of a proven effective walking program based on the Ottawa Panel CPG \[[@B3]-[@B5]\] and implemented through the use of a multifaceted KT intervention (Part I) \[[@B6]\]. This portion focuses on the "Outcome evaluation (Clinical outcomes)" phase of the Knowledge Translation Action Cycle **(KTAC)**\[[@B7],[@B8]\] introduced in part I \[[@B6]\].

Background
==========

Physical activity and quality of life
-------------------------------------

PA can exacerbate age-related decreases in joint health, functional status, and quality of life (QOL) \[[@B9]-[@B11]\]. Moreover, the prolonged physical inactivity observed in individuals suffering from arthritis increases their risk for chronic disease such as coronary heart disease, diabetes, hypertension, obesity and osteoporosis \[[@B12],[@B13]\].

A recent study reported that only 27.8% of individuals with OA engaged in PA on a regular basis (i.e. 20 minutes a day, 5 days per week, or 30 minutes per day, 3 days per week) \[[@B13]\]. Promotion of PA, especially in a community-based context, is a priority for health organizations serving the general population \[[@B13],[@B14]\] and is highly recommended for subgroups affected by chronic diseases including OA \[[@B15]-[@B17]\].

Various PA programs for OA have shown significant and beneficial effects on QOL at 2 and 3 months \[[@B18]-[@B24]\]. However, this effect was not maintained after a period of unsupervised PA \[[@B20],[@B21],[@B25]\]. According to Hurley \[[@B26]\], "exercise benefits people with OA while people are exercising; when they stop exercising the benefits can be maintained for a short time, but the gains are likely to be lost overtime unless individuals are actively encouraged to continue exercising".

Behavioural interventions
-------------------------

Behavioural interventions have been used with other chronic conditions to improve long-term maintenance of PA regimens with varying success. Patient education, health counselling, goal setting, telephone contacts, exercise logs, social/peer support and positive feedback either alone or in various combinations, have been studied in cardiovascular disease \[[@B27]-[@B30]\] and rheumatoid arthritis \[[@B31]\]. As with OA, multifaceted approaches appear to have the greatest impact on long-term adherence, degree of PA performed, and QOL.

The purpose of this randomized controlled trial **(RCT)** was to compare 1) improvements in quality of life **(QOL)** (primary outcome) and clinical outcomes such as pain, mobility and endurance; 2) adherence rates; and 3) confidence and self-efficacy after the implementation of a 12-month supervised community-based aerobic walking program (**SCAWP**) based on the Ottawa Panel clinical practice guidelines **(CPG**) \[[@B3]-[@B5]\] among three knowledge translation **(KT)** intervention arms. QOL, confidence, and self-efficacy were compared at 12- months (end of treatment) and at 18-months (6-months post-intervention). Adherence was compared during the intervention period at 3, 6, 9 and 12- months. Adherence, confidence and self-efficacy results are presented in part I of this manuscript.

Methods
=======

Design
------

A single blind randomized controlled trail was used for this study. The hypothesis of this study was that a supervised community-based walking program would have a positive impact on participants with mild to moderate OA of the knee, if they walked regularly as stated in the recommendations of the Ottawa Panel \[[@B3]-[@B5]\]. This community-based study was approved by the University of Ottawa Research Ethics Board as well as by the City of Ottawa Public Health Research Ethics Board. All participants signed informed consent. Please see part I for more details on the study design \[[@B6]\].

Sample and recruitment
----------------------

A total of 222 adults with mild to moderate OA of the knee were recruited from Ottawa, Ontario and Gatineau, Québec, Canada. Please see part I for inclusion/exclusion criteria \[[@B6]\].

Intervention
------------

Participants were randomly assigned to one of the three KT intervention groups using central randomization \[[@B32]\] and computer generated numbers \[[@B33]\]: 1) Walking and Behavioural intervention **(WB)** ( implementation strategy) (18 males, 57 females) which included the SCAWP with a behavioural intervention and an educational pamphlet on the benefits of walking; 2) Walking intervention **(W)** (implementation strategy) (24 males, 57 females) wherein participants only received the SCAWP intervention and the educational pamphlet; 3) Self-directed control **(C)** (dissemination strategy) (32 males, 52 females) wherein participants only received the educational pamphlet. All 3 groups were provided with pedometers and log books to be completed to measure physical performance and additional PA aside from the walking sessions. The KT and dissemination strategies were implemented over a 12-month duration and participants were assessed for additional 6 months (15 and 18-month assessments). A detailed description of each intervention can be found in part I of this manuscript.

Data collection
---------------

Participants were assessed by an independent evaluator at baseline and at each 3 month interval (months 3, 6, 9, 12) during the intervention period. Participants were then assessed at 3 and 6 months post-intervention during the follow-up period (months 15 and 18). Participants were asked to complete a collection of validated questionnaires as well as perform physical tests as each assessment.

Clinical outcome measures
-------------------------

### Health-related quality of life

The Arthritis Impact Measurement Scale (AIMS2) and the Short Form (SF-36) questionnaires were administered during patient evaluations. The scientific literature in rheumatology recommends that researchers use the AIMS2 and SF-36 concurrently, as they complement one another \[[@B34]-[@B36]\]. In support of their complementary roles, the detection of clinically important changes is enhanced through the use of a disease specific instrument (AIMS2), while a generic measure (SF-36) properly distinguishes different levels of self-reported general health statuses and co-morbidities not necessarily related to OA.

The SF-36 is the most widely used and extensively validated generic measure of health-related QOL \[[@B36]-[@B38]\]. The SF-36, which consists of 8 subscales and 36 questions, is a reliable and valid scale for several medical conditions, including rheumatic diseases \[[@B35],[@B36],[@B39]-[@B41]\]. Internal consistency via Cronbach's alpha ranged between 0.74 to 0.96 over the different sections \[[@B40]\]. Test-retest intra-class correlation coefficients range from 0.75 to 0.93 \[[@B41]\]. Validity testing revealed that the SF-36 correlates moderately with several other measures related to disease activity, pain, depression and QOL \[[@B36],[@B41]\]. The SF-36 was used to report QOL in several RCTs involving various PA programs designed for individuals with OA \[[@B19],[@B21],[@B24]\]. The responsiveness of this instrument was demonstrated in these studies by appropriate and expected changes in mean scores according to age, sex, marital status, severity of OA, and presence or absence of co morbid conditions. Mean scores also changed appropriately over time in response to the interventions. The aggregated SF-36 components are scored in which higher scores represented better health-related quality of life \[[@B42]\].

The Arthritis Impact Measurement Scale (AIMS2) is a disease-specific QOL scale \[[@B36]\] that consists of 101 items and includes various subscale scores \[[@B42]\]. The AIMS2 walking and bending sub-scale was considered as the primary outcome. All other AIMS2 sub-scales were used as secondary outcomes, since the use of the global scale could not be aggregated. The global AIMS2 scales are scored in which a low value indicated a higher health status \[[@B43],[@B44]\].This QOL instrument has been used in several walking program studies that included subjects with OA \[[@B18],[@B22],[@B45]\]. AIMS2 has been shown to possess good internal consistency (alpha coefficients ranging from 0.72 to 0.91) and good test-retest results (Intraclass correlation coefficients ranging from 0.78 to 0.94). The construct and criterion validity have also been examined. Standardized response means for changes in AIMS2 scores over 3 months ranged from 0.36 to 0.80 \[[@B36],[@B44]\].

Functional status was measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) (Bellamy and Buchanan, 1986). WOMAC is a self-administered multidimensional index containing dimensions for pain, stiffness and function. This five-point instrument has been shown to be valid and reliable in individuals with hip or knee rheumatic conditions, and is sensitive to change over time. The WOMAC questionnaire \[[@B45]\] has been adapted for lower extremity joints affected with OA, such as the knee or hip \[[@B19],[@B22],[@B45]-[@B48]\]. WOMAC is widely used and has been extensively validated \[[@B49],[@B50]\]. Furthermore, according to Rogers & Irrgang \[[@B50]\], the WOMAC pain and functional subscales exhibit excellent responsiveness. The minimal clinically important rehabilitation effects ranged from 0.80 to 1.01 \[[@B51]\].

Other quantitative functional outcomes such as walking endurance and gait speed \[[@B20],[@B22],[@B52]-[@B55]\] were measured using the 6-minute walk test \[[@B55]\] and Timed-up-and-Go test \[[@B56]\].

### Level of physical activity

Changes in level of PA were measured using the Seven Day Physical Activity Recall (7-day PAR) \[[@B57]-[@B59]\]. The 7-day PAR is a validated instrument in a calendar format in which a participant can indicate the duration (minutes per day), frequency (days per week) and intensity (multiples of basal metabolic rate). An adapted version of the 7-day PAR was included in the logbooks where PA was split into distinct walking and other physical activities.

Analysis
--------

A repeated measure mixed model was used to assess the change in health-related QOL measures (adjusted AIMS2 for age and co-morbidity and SF-36) as well as clinical outcomes from baseline to 12 months (end of intervention) and to 18 months (6 month follow-up post-intervention) among three study groups. The model included variables such as intervention group, study month, and an interaction term between the intervention group and study month. Missing data was assumed to be missing at random (MAR) in order to include incomplete data. Pair wise differences comparing each group to one another (W vs. C, W vs. WB, WB vs. C) were assessed. The repeated measure mixed model was used to compare the change of outcomes from baseline to the 18-month follow-up. Statistical analyses were performed using SAS (version 9.2, SAS Institute Inc., Cary, North Carolina), and statistical significance was defined as p \< 0.05.

Results
=======

Clinical outcome measures
-------------------------

### Quality of Life

#### Short-Form 36

There were no statistically significant results between the three groups for QOL measured with the SF-36 (Table [1](#T1){ref-type="table"}) with the exceptions of the variables "physical role functioning", "physical role", "pain index" and "standardized physical component". At 12-months, results favoured the W group for the "physical role" variable when compared to the WB group (p = 0.04). At 18-months, results favoured the W group for the "physical functioning" (p = 0.02) and "pain index" (p = 0.00) variables when compared to the WB group. The self-directed group was also favoured when compared either to the W or WB groups for the "physical functioning" (p = 0.01), "pain index" (p = 0.03) and "standardized physical component" (p = 0.00) variables.

###### 

Summary of SF-36 for three study arms

  **Variables**                     **Baseline**      **12 Months**     **18 Months**                                                                                               
  --------------------------------- ----------------- ----------------- ----------------- ----------------- ----------------- ----------------- ----------------- ----------------- ------------------
  Physical Functioning              79                69                74                44                43                41                44                42                36
  63.003 ± 18.332                   66.449 ± 19.157   67.275 ± 20.446   70.088 ± 18.819   68.127 ± 19.694   68.171 ± 26.381   68.157 ± 21.308   63.254 ± 25.705   75.694 ± 19.645   
                                                                        (0.250)           (0.982)           (0.234)           (0.836)           \*(0.012)         \*(0.015)         
  Role Physical                     78                69                74                44                44                41                44                42                36
  52.350 ± 40.064                   69.203 ± 35.393   56.757 ± 39.755   61.742 ± 39.755   59.659 ± 41.138   65.854 ± 42.484   57.386 ± 40.556   60.119 ± 40.971   68.519 ± 39.345   
                                                                        (0.909)           (0.063)           \*(0.044)         (0.864)           (0.058)           (0.071)           
  Pain Index                        78                69                74                44                44                41                44                42                36
  60.487 ± 16.040                   67.348 ± 18.261   62.149 ± 18.762   63.818 ± 19.134   63.795 ± 20.124   67.805 ± 18.378   65.045 ± 18.881   61.167 ± 18.322   67.444 ± 18.315   
                                                                        (0.581)           \*(0.026)         (0.082)           (0.491)           \*(0.030)         \*(0.003)         
  General Health Perceptions        79                68                74                44                44                41                44                42                36
  67.873 ± 18.214                   70.838 ± 20.465   70.635 ± 17.434   67.619 ± 17.484   68.926 ± 19.008   72.000 ± 18.358   69.307 ± 19.189   66.143 ± 20.483   69.917 ± 18.243   
                                                                        (0.223)           (0.089)           (0.605)           (0.226)           (0.496)           (0.051)           
  Vitality                          79                68                74                44                44                41                44                42                36
  58.481 ± 17.711                   60.588 ± 21.152   60.473 ± 18.984   62.045 ± 19.628   60.341 ± 19.778   64.756 ± 18.267   60.152 ± 21.858   58.929 ± 18.791   66.157 ± 17.839   
                                                                        (0.856)           (0.475)           (0.359)           (0.845)           (0.517)           (0.380)           
  Social Functioning                79                69                74                44                44                41                44                42                36
  80.380 ± 22.080                   85.507 ± 18.394   82.432 ± 20.474   79.545 ± 22.889   84.375 ± 18.309   85.671 ± 20.264   78.125 ± 26.704   84.226 ± 19.533   79.167 ± 21.547   
                                                                        (0.266)           (0.168)           (0.775)           (0.232)           (0.735)           (0.379)           
  Role Emotional                    78                69                74                44                44                41                44                42                36
  75.214 ± 37.000                   84.058 ± 29.488   74.324 ± 37.643   85.606 ± 30.835   81.061 ± 32.468   82.927 ± 35.057   75.000 ± 40.106   80.159 ± 31.286   82.407 ± 33.320   
                                                                        (0.949)           (0.170)           (0.144)           (0.597)           (0.290)           (0.574)           
  Mental Health Index               78                68                74                44                44                41                44                42                36
  76.500 ± 17.558                   77.588 ± 15.670   80.365 ± 13.974   78.364 ± 16.007   80.000 ± 14.823   81.366 ± 14.411   77.114 ± 17.926   77.405 ± 15.759   79.333 ± 14.890   
                                                                        (0.735)           (0.909)           (0.822)           (0.597)           (0.880)           (0.486)           
  Health Transition Item            79                69                74                43                43                41                44                42                36 2.639 ± 0.899
  2.975 ± 0.987                     3.014 ± 0.737     2.959 ± 0.818     2.419 ± 0.852     2.698 ± 0.914     2.463 ± 0.840     2.727 ± 0.924     3.024 ± 1.024     (0.459)           
                                                                        (0.821)           (0.564)           (0.415)           (0.832)           (0.356)                             
  Standardized Physical Component   77                68                74                44                43                41                44                42                36
  40.516 ± 8.598                    43.645 ± 8.656    41.996 ± 9.100    42.508 ± 9.229    42.192 ± 10.066   43.464 ± 9.409    42.820 ± 9.240    40.909 ± 11.038   45.149 ± 8.930    
                                                                        (0.804)           (0.135)           (0.074)           (0.703)           \*(0.009)         \*(0.002)         
  Standardized Mental Component     77                68                74                44                43                41                44                42                36
  52.914 ± 10.845                   53.812 ± 8.639    53.556 ± 8.995    53.819 ± 9.852    54.476 ± 7.329    55.162 ± 8.540    51.993 ± 11.000   53.922 ± 9.023    53.101 ± 9.914    
                                                                                          (0.595)           (0.436)           (0.795)           (0.688)           (0.638)           (0.937)

The selected results for SF-36 analysis were presented at baseline, at end of intervention (12 months), and at 6-months post intervention (18- month follow-up). The mean values of the 8 domains of the SF-36 for the three study groups are detailed in Table [1](#T1){ref-type="table"}. After the 12-month intervention phase of the walking program, the self-directed group (C) had the highest mean (± SE) "physical role" score 65.85(±42.48 ). The WB group demonstrated the lowest mean pain index score 63.80 (±20.12). At 18-months, the self-directed group (C) demonstrated the highest mean scores for "physical functioning" 75.69(±19.65), "pain index" 67.44(±18.32), and " standardized physical component" 45.15(±8.93). The WB group had the lowest mean scores for "physical functioning" 63.25(±25.71), "pain index" 61.17(±18.32), and " standardized physical component" 40.91(±11.04).

#### Arthritis Impact Measurement Scale 2 (AIMS2)

The AIMS2 analyses were performed at baseline, at end of intervention (12- months), and at 6-months post intervention (18- month follow-up) (Table [2](#T2){ref-type="table"}). At 12-months, statistical significance was observed when the WB group was compared to the self-directed group (C), mean results (± SE) favoured the self-directed group (C) for the "hand and finger" (p = 0.04), "social activity" (p = 0.01), "arthritis pain" (p = 0.02), "symptoms component" (p = 0.02)and "social interaction component" (p = 0.01) variables. At 12-months, statistical significance was only observed when the W group was compared to the self-directed group (C), mean results (± SE) favoured the self-directed group (C) for the "social activity" (p = 0.01) variable.

###### 

Summary of AIMS2 for three study arms

  **Variables**                  **Baseline**    **12 Months**   **18 Months**                                                                                   
  ------------------------------ --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------
  Mobility                       79              69              74              44              44              41              44              42              36
  1.281 ± 1.511                  1.058 ± 1.621   1.169 ± 1.479   0.614 ± 1.017   0.773 ± 0.866   0.720 ± 1.090   0.815 ± 1.189   0.869 ± 1.215   0.486 ± 0.898   
                                                                 (0.662)         (0.276)         (0.121)         (0.714)         (0.086)         (0.156)         
  Walking and Bending            79              69              74              44              44              41              44              42              36
  4.044 ± 2.047                  3.513 ± 2.538   3.792 ± 2.494   3.364 ± 2.216   3.695 ± 2.248   3.085 ± 2.490   3.670 ± 2.323   3.702 ± 2.402   2.708 ± 2.112   
                                                                 (0.900)         (0.081)         (0.094)         (0.656)         \*(0.044)       (0.099)         
  Hand and Finger                79              68              74              44              44              41              44              42              36
  0.704 ± 1.061                  0.647 ± 1.033   0.412 ± 0.904   0.602 ± 0.931   0.455 ± 0.689   0.744 ± 1.937   0.616 ± 1.195   0.693 ± 0.917   0.569 ± 1.196   
                                                                 (0.127)         \*(0.039)       (0.573)         (0.314)         (0.552)         (0.678)         
  Arm Function                   79              68              74              44              44              41              43              42              36
  0.363 ± 0.795                  0.368 ± 1.010   0.264 ± 0.642   0.295 ± 0.726   0.591 ± 1.448   0.220 ± 0.699   0.581 ± 1.170   0.405 ± 0.843   0.194 ± 0.511   
                                                                 (0.451)         (0.253)         (0.673)         (0.175)         (0.635)         (0.369)         
  Self Care                      79              69              74              44              44              41              43              42              36
  0.391 ± 1.632                  0.045 ± 0.247   0.194 ± 1.179   0.114 ± 0.509   0.028 ± 0.132   0.091 ± 0.358   0.087 ± 0.572   0.104 ± 0.435   0.000 ± 0.000   
                                                                 (0.801)         (0.726)         (0.541)         (0.541)         (0.409)         (0.147)         
  Household Tasks                79              69              74              44              44              41              44              42              36
  0.539 ± 1.093                  0.272 ± 0.806   0.450 ± 1.549   0.341 ± 1.004   0.114 ± 0.279   0.274 ± 0.713   0.412 ± 0.933   0.565 ± 1.379   0.122 ± 0.468   
                                                                 (0.924)         (0.879)         (0.802)         (0.679)         \*(0.024)       (0.053)         
  Social Activity                79              69              74              44              43              41              44              42              36
  4.530 ± 1.723                  4.449 ± 1.774   4.639 ± 2.050   4.727 ± 1.573   4.453 ± 1.886   3.732 ± 2.188   4.625 ± 1.840   4.720 ± 1.860   4.281 ± 2.141   
                                                                 \*(0.013)       \*(0.006)       (0.767)         (0.944)         (0.233)         (0.187)         
  Support From Family            79              69              74              44              43              40              44              42              36
  1.907 ± 2.286                  1.778 ± 1.938   2.204 ± 2.158   1.989 ± 2.269   2.253 ± 2.379   2.328 ± 2.356   1.932 ± 2.437   1.979 ± 2.052   2.743 ± 2.606   
                                                                 (0.605)         (0.100)         (0.237)         (0.308)         (0.824)         (0.414)         
  Arthritis Pain                 79              69              73              44              44              41              44 3.           42              35
  4.396 ± 1.907                  3.813 ± 2.175   4.270 ± 2.426   3.494 ± 2.383   3.793 ± 2.285   3.494 ± 2.383   440 ± 2.409     3.642 ± 2.157   3.400 ± 2.228   
                                                                 (0.523)         \*(0.019)       (0.075)         (0.836)         \*(0.030)       \*(0.013)       
  Work                           37              25              40              15              11              18              12              9               14
  2.095 ± 2.302                  1.975 ± 2.193   1.828 ± 1.958   1.542 ± 1.828   0.625 ± 0.791   1.875 ± 1.561   2.188 ± 2.450   2.083 ± 1.849   1.830 ± 1.826   
                                                                 (0.536)         (0.171)         (0.428)         (0.730)         (0.825)         (0.608)         
  Level of Tension               79              69              74              44              43              40              44              42              36
  3.327 ± 1.850                  3.338 ± 1.900   3.030 ± 1.718   3.085 ± 1.692   3.078 ± 1.731   2.972 ± 1.897   3.313 ± 1.969   3.012 ± 1.799   2.815 ± 1.601   
                                                                 (0.728)         (0.810)         (0.916)         (0.804)         (0.825)         (0.628)         
  Mood                           79              69              74              44              42              40              44              42              36
  2.036 ± 1.548                  1.937 ± 1.479   1.726 ± 1.168   1.795 ± 1.636   1.818 ± 1.324   1.478 ± 1.278   1.795 ± 1.909   1.893 ± 1.290   1.531 ± 1.301   
                                                                 (0.686)         (0.224)         (0.397)         (0.622)         (0.449)         (0.194)         
  Satisfaction                   79              69              74              43              44              41              44              42              36
  2.567 ± 1.580                  2.746 ± 1.762   2.523 ± 1.458   2.113 ± 1.818   2.333 ± 1.728   2.127 ± 1.640   2.183 ± 2.080   2.657 ± 1.885   1.934 ± 1.570   
                                                                 (0.529)         (0.800)         (0.704)         (0.599)         (0.305)         (0.108)         
  Health Perception              79              68              72              44              43              39              42              42              34
  3.890 ± 2.417                  3.340 ± 2.159   3.572 ± 2.464   3.644 ± 2.369   3.495 ± 1.778   3.340 ± 1.877   3.340 ± 1.952   3.658 ± 2.310   3.438 ± 1.926   
                                                                 (0.420)         (0.117)         (0.418)         (0.311)         (0.473)         (0.073)         
  Arthritis Impact               76              65              70              39              40              36              34              39              30
  3.191 ± 2.757                  2.769 ± 2.259   2.929 ± 2.407   2.372 ± 1.809   2.500 ± 2.334   2.222 ± 1.962   1.985 ± 2.112   3.013 ± 2.512   2.250 ± 1.897   
                                                                 (0.431)         (0.077)         (0.308)         (0.317)         (0.140)         \*(0.011)       
  Physical Component             79              68              74              44              44              41              43              42              36
  1.224 ± 0.830                  0.991 ± 0.777   1.047 ± 0.747   0.883 ± 0.845   0.943 ± 0.549   0.856 ± 0.771   1.039 ± 1.005   1.057 ± 0.753   0.676 ± 0.612   
                                                                 (0.554)         (0.352)         (0.121)         (0.562)         \*(0.011)       \*(0.040)       
  Affect Component               79              69              74              44              42              40              44              42              36
  2.681 ± 1.570                  2.637 ± 1.505   2.378 ± 1.344   2.440 ± 1.502   2.438 ± 1.436   2.225 ± 1.445   2.554 ± 1.806   2.452 ± 1.423   2.173 ± 1.368   
                                                                 (0.937)         (0.690)         (0.623)         (0.934)         (0.835)         (0.762)         
  Symptoms Component             79              69              73              44              44              41              44              42              35
  4.372 ± 1.907                  3.813 ± 2.175   4.270 ± 2.426   3.523 ± 2.360   3.793 ± 2.285   3.494 ± 2.383   3.440 ± 2.409   3.642 ± 2.157   3.400 ± 2.228   
                                                                 (0.523)         \*(0.019)       (0.075)         (0.836)         \*(0.030)       \*(0.013)       
  Social Interaction Component   79              69              74              44              43              40              44              42              36
  3.241 ± 1.578                  3.114 ± 1.552   3.421 ± 1.614   3.358 ± 1.506   3.353 ± 1.698   3.033 ± 1.977   3.278 ± 1.906   3.350 ± 1.556   3.512 ± 1.965   
                                                                 (0.081)         \*(0.006)       (0.268)         (0.388)         (0.539)         (0.127)         
  Role Component                 37              25              40              15              11              18              12              9               14
  2.095 ± 2.302                  1.975 ± 2.193   1.828 ± 1.958   1.542 ± 1.828   0.625 ± 0.791   1.875 ± 1.561   2.188 ± 2.450   2.083 ± 1.849   1.830 ± 1.826   
                                                                                 (0.536)         (0.171)         (0.428)         (0.730)         (0.825)         (0.608)

At 18- months, when the WB group was compared to the self-directed group (C), mean results (± SE) favoured the self-directed group for the "walking and bending" (p = 0.044), "household tasks" (p = 0.02), "arthritis pain" (p = 0.03), "physical component" (p = 0.01), and "symptoms component" (p = 0.03) variables. When the W group was compared to the WB group, results favoured the W group for the "arthritis pain" (p = 0. 01), "arthritis impact" (p = 0. 01), "physical component" (p = 0.04), and "symptoms component" (p = 0. 01) variables.

At 12-months, the WB group demonstrated the highest mean scores for the "arthritis pain" 3.79 (±2.29) and "symptoms component" 3.79 (±2.29) variables, and the lowest score 0.46 (±0.69) for the "hand and finger" variable. The W group had the highest mean scores for the "social activity" 4.73 (±1.57) and "social interaction component" 3.36 (±1.51) variables. The self-directed group (C) had the lowest "symptoms component" score 3.94 (±2.38). At 18-months, the WB group demonstrated the highest mean scores for the "walking and bending" 3.70(±2.40), "household tasks" 0.57(±1.38), "arthritis pain" 3.64(±2.16), "physical component" 1.06(±0.75), and "symptoms component" 3.64(±2.16) variables. The self-directed group(C) had the lowest scores for the "walking and bending" 2.708(±2.11), "arthritis pain" 3.40(±2.23), "physical component" 0.68(±0.61), and "symptoms component" 3.40(±2.23) variables.

Clinical outcomes
-----------------

### Functional status

At 12 and 18- months, improvements were observed in each three comparative groups as the overall item scores decreased when compared to baseline (Table [3](#T3){ref-type="table"}). No statistical significance was demonstrated for total WOMAC scores at 12-months. At 18 months, the self-directed (C) group demonstrated the lowest mean (± SD) "pain" scores 23.50 (±17.78). The only statistically significant difference in total functional scores found between the 3 groups was at 18-months which favoured the W group when compared to the WB group (±16.74).

###### 

Summary of WOMAC for three study arms

  **Variables**       **Baseline**    **12 Months**   **18 Months**                                                                                   
  ------------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- -----------
  Pain                79              69              73              43              42              41              43              42              35
  31.15 ± 14.29       26.81 ± 14.92   30.30 ± 16.47   24.65 ± 15.78   25.32 ± 15.98   25.00 ± 19.44   23.60 ± 15.09   26.16 ± 17.97   23.50 ± 17.78   
                                                      (0.572)         (0.238)         (0.522)         (0.863)         (0.157)         (0.096)         
  Stiffness           79              69              71              44              41              40              43              42              35
  38.90 ± 18.01       36.41 ± 18.90   39.08 ± 19.81   30.96 ± 22.31   30.79 ± 19.58   28.43 ± 20.41   29.94 ± 20.43   31.40 ± 20.75   27.14 ± 18.80   
                                                      (0.125)         (0.405)         (0.486)         (0.494)         (0.423)         (0.890)         
  Physical Function   79              68              72              44              38              40              43              42              35
  28.16 ± 15.41       27.65 ± 18.22   26.89 ± 16.34   24.48 ± 13.79   25.27 ± 15.70   25.06 ± 13.53   18.20 ± 14.63   24.15 ± 17.24   19.40 ± 17.08   
                                                      (0.672)         (0.903)         (0.763)         (0.582)         (0.381)         (0.140)         
  Total WOMAC Score   79              68              70              43              41              40              43              42              35
  29.70 ± 14.09       28.27 ± 16.42   28.95 ± 15.28   21.05 ± 13.62   23.60 ± 13.61   22.32 ± 17.77   20.30 ± 13.97   25.58 ± 16.60   20.90 ± 16.74   
                                                                      (0.612)         (0.475)         (0.821)         (0.464)         (0.129)         \*(0.019)

W: Walking only group; WB: Walking and Behavioural Group; C: Self-directed group (unsupervised/self-directed); N: number of subjects in each comparative group; SD: standard deviation; vs: versus; data is presented as mean (standard deviation); P: p-value (statistical significance); \* Statistically significant; WOMAC: Western Ontario MacMaster Osteoarthritis Index.

### Walking endurance

There were no statistically significant results for the 6-min walk test among the three groups after 12 and 18- months (Table [4](#T4){ref-type="table"}). Distance (in meters) increased during the 6- minute walk test at both 12 and 18 months when compared to baseline among all three groups (Table [5](#T5){ref-type="table"}). At 12- months, individuals in the W group had the highest score 524.86 (±106.52). The self-directed (C) group had the highest score 540.35 (±103.37) at 18 months.

###### 

Summary of 6-minute walking for three study arms (6 Minute Walk Test)

                   **Baseline**     **12 Months**    **18 Months**                                                                                            
  ---------------- ---------------- ---------------- ----------------- ---------------- ----------------- ---------------- ---------------- ----------------- -------
  6-min walk       79               68               74                44               41                40               42               39                35
  456.45 ± 87.62   475.27 ± 90.77   490.89 ± 99.30   524.86 ± 106.52   509.41 ± 82.43   520.52 ± 115.14   492.91 ± 86.95   500.15 ± 77.46   540.35 ± 103.37   
                                                                       0.063            0.535             0.215            0.366            0.318             0.902

W: Walking only group; WB: Walking and Behavioural Group; C: Self-directed group (unsupervised/self-directed); N: number of subjects in each comparative group; SD: standard deviation; vs: versus; data is presented as mean (standard deviation); P: p-value (statistical significance); \* Statistically significant; 6mwt: 6-min walk test (walking endurance).

### Gait speed

There were no statistically significant results at both 12 months and 18-months for gait speed (Table [5](#T5){ref-type="table"}). These results were similar to walking endurance, as gait speed was calculated using the 6 minute walk test. At 12 months, the W group had the highest score 1.458(±0.296). At 18-months the self-directed (C) group had the highest score 1.501 (±0.287).

###### 

Summary of Gait Speed for three study arms

                  **Baseline**    **12 Months**   **18 Months**                                                                                   
  --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------
  Gait Speed      79              68              74              44              41              40              42              39              35
  1.268 ± 0.243   1.320 ± 0.252   1.364 ± 0.276   1.458 ± 0.296   1.415 ± 0.229   1.446 ± 0.320   1.369 ± 0.242   1.389 ± 0.215   1.501 ± 0.287   
                                                                  (0.063)         (0.535)         (0.215)         (0.366)         (0.318)         (0.902)

W: Walking only group; WB: Walking and Behavioural Group; C: Self-directed group (unsupervised/self-directed); N: number of subjects in each comparative group; SD: standard deviation; vs: versus; data is presented as mean (standard deviation); P: p-value (statistical significance); \* Statistically significant.

### Timed up and Go

There were no statistically significant results for the Timed up and Go among the three groups at 12 and 18- months (Table [6](#T6){ref-type="table"}). At 12 and 18-months, Timed up and Go scores (time in seconds) decreased in all three groups when compared to baseline (Table [4](#T4){ref-type="table"}). Timed up and Go scores were lowest for all 3 groups at 12 months when compared to 18 months. At 12 months, the WB group had the lowest score 8.10 (±1.54) compared to the other two groups. At 18 months, the self-directed (C) group had the lowest score 7.88 (±1.89).

###### 

Summary of Timed Up and Go for three study arms

                **Baseline**   **12 Months**   **18 Months**                                                                         
  ------------- -------------- --------------- --------------- ------------- ------------- ------------- ------------- ------------- ---------
  TUG           79             69              74              44            41            41            42            39            35
  9.04 ± 2.72   8.58 ± 2.45    8.34 ± 3.28     8.12 ± 2.44     8.10 ± 1.54   7.65 ± 1.79   8.41 ± 2.05   8.40 ± 1.36   7.88 ± 1.89   
                                                               (0.796)       (0.770)       (0.576)       (0.860)       (0.434)       (0.525)

W: Walking only group; WB: Walking and Behavioural Group; C: Self-directed group (unsupervised/self-directed); N: number of subjects in each comparative group; SD: standard deviation; vs: versus; data is presented as mean (standard deviation); p: p-value (statistical significance); \* Statistically significant TUG: timed up and go.

### Level of physical activity

After participating in the 12-month walking program \[[@B3]-[@B5]\], the WB group demonstrated the highest increase in activity level (Table [7](#T7){ref-type="table"}). Statistical significance was not reached for "Leisure-Time Physical Activity" variables. At 12 months, the WB demonstrated the highest mean scores for "Leisure-Time Physical Activity Walking only" 13.89 (±12.40) and for "Leisure-Time Physical Activity Walking and other activities" 19.77 (±15.85). At 18 months, the self-directed (C) group demonstrated the highest mean score of 16.88 (±17.50) for "Leisure-Time Physical Activity Walking only" and 24.18 (±25.59) for "Leisure-Time Physical Activity Walking & other activities". At 12 and 18 months, the WB group had the highest mean score for "Occupational/Domestic Activity Walking only" 33.00 (±70.75) and 33.07 (±39.04) and the highest "Occupational/Domestic Activity Walking and other activities" mean score 41.48 (±61.94). Statistical significance was demonstrated for "Occupational/Domestic Activity Walking and other activities" mean scores at 12- months 27.99 (±37.28) and 18 months 26.13 (±15.64) for the WB group.

###### 

Summary of 7 day Physical Activity Recall for three study arms

  **Variables**        **Baseline**    **12Months**    **18Month**                                                                                     
  -------------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- -----------
  LTA Walking Only     63              49              56              42              37              38              40              33              32
  12.09 ± 13.09        13.92 ± 16.50   12.45 ± 14.96   12.22 ± 7.86    13.89 ± 12.40   12.68 ± 11.20   12.20 ± 9.90    16.40 ± 18.72   16.88 ± 17.50   
                                                       (0.816)         (0.816)         (0.987)         (0.261)         (0.932)         (0.303)         
  LTA Walking +Other   69              61              62              43              38              41              41              35              33
  16.18 ± 21.49        16.43 ± 18.86   19.74 ± 22.87   15.34 ± 10.23   19.77 ± 15.85   16.01 ± 14.14   16.46 ± 13.17   22.15 ± 21.21   24.18 ± 25.59   
                                                       (0.633)         (0.139)         (0.294)         (0.404)         (0.602)         (0.165)         
  ODA Walking Only     35              28              34              9               11              13              17              14              8
  20.75 ± 25.69        11.92 ± 12.42   18.17 ± 25.98   17.10 ± 21.03   33.00 ± 70.75   11.05 ± 8.39    22.33 ± 26.10   33.07 ± 39.04   12.04 ± 5.64    
                                                       (0.675)         \*(0.040)       (0.113)         (0.601)         (0.076)         (0.140)         
  ODA Walking +Other   60              47              55              26              24              30              29              24              19
  31.31 ± 36.00        19.77 ± 25.61   26.85 ± 30.88   22.63 ± 20.97   41.48 ± 61.94   27.99 ± 37.28   23.34 ± 22.40   27.97 ± 33.15   26.13 ± 15.64   
                                                                       (0.273)         \*(0.047)       \*(0.003)       (0.198)         (0.331)         \*(0.021)

W :Walking only group; WB: Walking and Behavioural Group; C: Self-directed group (unsupervised/self-directed); N: number of subjects in each comparative group; SD: standard deviation; vs: versus; data is presented as mean (standard deviation); p: p-value (statistical significance); \* Statistically significant; ODA: Other domestic activities; LTA: Leisure time activities.

Discussion
==========

We attempted to find the best way to implement a proven effective SCAWP from a clinical point of view \[[@B3]-[@B5]\]. As expected from the Ottawa Panel CPG on SCAWP \[[@B3]-[@B5]\], QOL as well as clinical outcomes of this RCT improved among participants with mild to moderate OA in each of the three comparative groups. However, very few statistically significant differences were observed for QOL and clinical outcomes over a long duration after the 12-month intervention phase and the 18-month follow-up phase. Results varied among the three groups depending on which outcomes were considered.

Participants from each group showed improvements in QOL and clinical outcomes measurements as they benefited from the walking component which has found be effective according to the Ottawa Panel CPGs \[[@B3]-[@B5]\]. The behavioural component facilitated the implementation of The Ottawa Panel CPG on SCAWP \[[@B3]-[@B5]\] over a short-term period (See part I), but did not have a direct impact on QOL and clinical outcomes \[[@B6]\].

Quality of life (QOL) outcomes
------------------------------

Various PA programs, including walking programs for OA, have improved QOL when compared to a control group with no walking involvement over a short-term period \[[@B18]-[@B24]\]. However, this effect was not maintained after a period of unsupervised PA at 6 months \[[@B24]\], 9 months \[[@B20]\], and 18 months \[[@B25]\]. This RCT used a self-directed walking group as comparator.

Surprisingly, all statistically significant results favoured the self-directed group (C) group compared to the two walking groups (W and WB groups) with QOL improvements at 12 and 18 months. The behavioural component of the WB group was expected to improve participant adherence to the program over a long period of time, allowing participants to benefit from the proven effective walking program by improving and maintaining QOL and clinical outcomes. Some explanations as to why participants in the self-directed (C) group demonstrated a higher QOL score may be due to the development of fewer health problems and fewer difficulties with transportation resulting in less attrition to the study. In addition, participants in the self-directed (C) group may not have experienced as many barriers as the other two groups in order to engage in walking activities for at least 3 times a week. This group had the comfort of being around their own environment, especially for those who were not retired and still working. These facilitators may have contributed to the improvement of the participants' QOL compared to the other groups which were required to travel regularly to the walking club.

Although the behavioural component of the WB group demonstrated the highest compliance rate for the first three months (Part I), they did not exhibit the highest QOL scores \[[@B6]\]. The self-directed (C) group contained the highest dropout rate, leading one to wonder if only participants with a higher QOL decided to adhere to regular walking.

Clinical outcomes
-----------------

The results of primary RCTs which served to develop Ottawa Panel CPGs \[[@B3]-[@B5]\] revealed that 10--60 minute aerobic walking programs for OA are proven effective to reduce pain intensity \[[@B18],[@B22],[@B47],[@B52],[@B53],[@B60]-[@B62]\], to reduce morning stiffness \[[@B20]\] , to increase strength \[[@B55],[@B63]\], to improve walking endurance \[[@B52],[@B64]\] , to better manage stairs climbing \[[@B59],[@B60],[@B62]\], to increase the number of steps performed per day \[[@B62]\], to build self-efficacy on stairs and in walking \[[@B65]\], to improve functional status \[[@B24],[@B47],[@B59],[@B64]-[@B66]\] and contribute to enhance QOL \[[@B20],[@B24],[@B47],[@B52],[@B67]\] when compared to a control group with no involvement of walking.

The nature of the walking program involved in the three comparative groups of this KT RCT demonstrated no differences between groups. The results of Evick et al. \[[@B47]\] revealed that a home-based exercise program is as effective as a supervised facility-based walking program for significantly improving pain relief, physical function, and quality of life at follow-up 3 months. Talbot et al. \[[@B55]\] observed that a home-based walking combined with education compared to education only improved the number of steps walked per day, improved the amount of time to climb stairs, and improved strength after the 12 week intervention and at follow-up 3- months post-intervention. The combined walking and education group also demonstrated improved pain relief at follow-up 3-months post intervention. Similar to a study by Minor et al. \[[@B20]\], the self-directed (C) group which was home-based, demonstrated the greatest improvements in clinical outcomes.

PA creates a motor evoked potential drop which decreases the corticomotor excitability which consequently reduces pain \[[@B68]\]. In a trial using rats, exercise has been shown to reverse signs of neuropathic pain and increase endogenous opioid content in brainstem regions which are important for pain modulation \[[@B69],[@B70]\]. Several PA programs, including walking, have been shown to result in decreased pain in the lower extremities in those suffering from OA \[[@B18],[@B20],[@B22],[@B47],[@B53],[@B67],[@B71],[@B72]\]. In these studies, the duration of the programs varied between 2 and 6 months. The study by Minor \[[@B20]\] demonstrated that the reduction in pain persisted after completion of the supervised aerobic walking program (3 and 9-month follow-up) if subjects continued to engage in PA. In this RCT, knee pain reduction, decreased morning stiffness and improved functional status were observed in all three comparative groups.

Surprisingly, there were no statistically significant results for "Leisure-Time Physical Activity" compared to "Occupational/Domestic Activity". One reason for these results may be that long term goal setting, included in the Pace-ex program for those in the WB group, were not based solely on walking activities and included any daily activities (e.g. weight loss). The two other comparative groups did not contain a goal setting intervention. In addition, baseline results illustrated that participants in the self-directed (C) group received a higher level of education. Strong associations have been found between level of education, physical fitness level, and amount of leisure activity.

Limitations
-----------

A major limitation of this study was the high attrition rate in each implementation and dissemination groups. As a result, validity of long-term results at 12-months end of intervention and at 18-months follow-up is questionable. Participants in the self-directed (C) group had initial lower values (poorer QOL) while participants in WB group demonstrated higher baseline values (higher QOL) for the physical components of the SF-36 and AIMS2 questionnaires. This situation may have lead to a potential bottom effect, creating larger room for QOL (SF-36) improvements for the self-directed (C) group and a potential ceiling effect for the WB group, resulting in smaller incremental improvements for QOL.

The use of the AIMS2 questionnaire among this specific population is debatable. The study subjects enrolled in this RCT were quite functional according to our inclusion criteria. They had to experience a low level degree of pain intensity and must have been able to walk for more than 20 minutes consecutively. AIMS2 is a QOL measurement designed for individuals with more severe physical conditions. This may have led to a potential ceiling effect on certain sub-scales such as the physical components.

Another limitation may have been the nature of the self-directed (C) group. The intervention among this group consisted solely of the use of a pamphlet on walking. As a result, the self-directed (C) group was not an inactive group, and walked regularly according to their self-reported logbook reports. We believe that the self-directed group (C) benefited just as much as the other two groups from the positive effects of walking.

Lastly, there were missing data from the 7-day PAR questionnaire as not all participants completed their logbooks and had difficulties remembering which activities were performed, resulting in a potential recall bias.

Implications
------------

This RCT was a long-term KT as well as compliance study which addressed questions of clinical and scientific importance. This study was designed to improve the understanding of efficacy of KT strategies to promote the adoption and maintenance of a community-based proven effective walking program for OA in order to improve the QOL of participants. Results of this study revealed that a community-based location or home-based walking program may be an effective strategy to manage OA of the knee.

Conclusions
===========

The three walking groups demonstrated globally equivalent results for the implementation of KT strategies to improve QOL and clinical outcomes over a long-term period (12 and 18-months).
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